Related Experiment Videos
5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline
Journal of Medicinal Chemistry
|January 1, 1979
Abstract:
Treatment of daunorubicin with methanolic ammonia affords 5-iminodaunorubicin, the first quinone-modified analogue of either daunorubicin or adriamycin. This product retains antileukemic activity in mice, is less cardiotoxic by electrocardiographic measurements in rats, and is nonmutagenic in Salmonella typhimurium (Ames test).